subscribeSubscribe
price-trendAsk Us
ViiV’s Rukobia wins EU authorisation to treat multidrug-resistant HIV

ViiV’s Rukobia wins EU authorisation to treat multidrug-resistant HIV
Lucy Parsons PHARMATIMES
10 Feb 2021
Share Share
ViiV`s HIV drug Rukobia gets EC marketing authorisation

ViiV`s HIV drug Rukobia gets EC marketing authorisation
PHARMAFILE
09 Feb 2021
Share Share
GSK snags FDA nod for Rukobia in multidrug-resistant HIV

GSK snags FDA nod for Rukobia in multidrug-resistant HIV
Angus Liu FIERCE PHARMA
06 Jul 2020
Share Share
ViiV Healthcare Announces US FDA Approval for Rukobia (fostemsavir)

ViiV Healthcare Announces US FDA Approval for Rukobia (fostemsavir)
BUSINESSWIRE
02 Jul 2020
Share Share
ViiV Healthcare submits regulatory application to the EMA for fostemsavir

ViiV Healthcare submits regulatory application to the EMA for fostemsavir
BUSINESS WIRE
11 Jan 2020
Share Share